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any  cancers  are  a  result  of  genetic 
changes that either inactivate a tumour 
suppressor gene or create an oncogenic 
form of a normal gene. However, a suppressor gene 
can also be inactivated by a process called DNA 
methylation, which involves an enzyme called 
DNA methylase adding methyl groups to sites at 
or near the gene (Baylin and Jones, 2011). This 
process is said to be ‘epigenetic’ because the 
sequence of bases in the DNA is not changed.
However, the term epigenetic does not simply 
mean a non-genetic alteration that influences 
phenotype; it also encompasses the idea of inherit-
ance. This consideration leads to two questions. 
First, how do tumour suppressor genes get methyl-
ated? Second, how is DNA methylation of tumour 
suppressor  genes  inherited  through  multiple 
generations? Now, in eLife, Michael Green and 
colleagues at the University of Massachusetts—
including Ryan Serra and Minggang Fang as joint 
first authors—build on previous work performed 
in  the  Green  laboratory  (Gazin  et  al.,  2007; 
Palakurthy et al., 2009; Wajapeyee et al., 2013) 
to demonstrate that DNA methylation of tumour 
suppressor  genes  is  controlled  by  a  transcrip-
tional regulatory pathway that is triggered by an 
oncogene. These findings raise the question of 
whether DNA methylation really is epigenetic 
(Serra et al., 2014).
There are two basic models for how tumour 
suppressor genes can be methylated: the stochas-
tic model and the instructive model (Figure 1). In 
the stochastic model, which is implicitly favored   
in the literature, methylation of tumour suppressor 
genes occurs by chance, with the resulting cells 
having a selective growth advantage. During the 
replication of DNA that has been methylated, 
each new molecule of DNA is hemi-methylated: 
that is, one strand is methylated and one strand 
is not. DNA methylases then add methyl groups 
to the strands that are not methylated, thereby 
maintaining the methylation pattern in the next 
generation (Figure 1A). One problem with the 
stochastic model, rarely if ever considered, is that 
the methylated sites on tumour suppressor genes 
are commonly located in close proximity, and it is 
unclear how this could occur by a random process.
In the instructive model, an oncogene starts a 
series of specific molecular events that culminates 
in DNA methylation of the tumour suppressor 
gene (Figure 1B). The key distinction between the 
two models is whether the DNA methylase is spe-
cifically targeted to the tumour suppressor genes 
or instead non-specifically methylates sites on a 
genome-wide basis. Such targeted or non-targeted 
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modes of action are analogous to those of his-
tone acetylases and other chromatin-modifying 
activities that are involved in transcriptional regu-
latory mechanisms (Struhl, 1998). In particular, 
classical transcriptional activation and repression 
mechanisms involve the targeted recruitment of 
chromatin-modifying activities to specific genes, 
whereupon they create local domains of histone 
modifications and  either increase or decrease the 
transcriptional output.
The  recent  work  by  Green  and  colleagues   
utilised a genome-scale RNA interference screen 
to identify genes that are critical for silencing one 
particular gene location—the hypermethylated 
INK4-ARF tumour suppressor locus—in a human 
colorectal cancer cell line (Serra et al., 2014). 
This cell line, like some other cancer cells, contains 
a mutation of the gene encoding a protein called 
KRAS.
Detailed molecular analyses of these genes 
(and their gene products) in several colorectal cell 
lines with this mutation, and in diseased tissue 
samples, reveal the following pathway (Figure 1B). 
The KRAS protein stimulates enzymes that ulti-
mately inhibit the degradation of a transcription 
factor called ZNF304, thereby increasing its con-
centration in the cell nucleus. This transcription 
factor can then recruit a co-repressor complex 
that includes a DNA methylase and two other 
proteins (Figure 1B). The end result is that the 
DNA is methylated at a particular location and 
that transcription of the tumour suppressor gene 
is repressed.
This  pathway  is  a  classical  transcriptional 
mechanism where DNA-binding proteins recruit 
chromatin-modifying  activities,  but  with  the   
additional twist of the recruitment of the DNA 
methylase and the subsequent DNA methylation. 
Therefore,  maintenance  of  DNA  methylation 
requires the continued presence of the proteins 
that are directly associated with the target locus, or 
are required for this association. The inactivation 
of any of these proteins leads to the loss of DNA 
methylation and transcriptional silencing. Lastly, 
and again typical of transcriptional mechanisms, 
the pathway affects not just INK4-ARF, but plays 
a key role in the methylation of around 50 other 
genes.
This and an earlier example in a mouse cancer 
cell line (Gazin et al., 2007; Wajapeyee et al., 
2013) strongly suggest that, like histone modifi-
cations, DNA methylation is not epigenetically 
inherited. Instead, it is maintained by an instruc-
tive  transcriptional  mechanism  that  represses 
multiple genes. As methylation is greatly diminished 
if any component of the transcriptional pathway 
Figure 1. The stochastic and instructive models for 
DNA methylation of tumour suppressor genes. (A) Prior 
to replication, both strands of the DNA are methylated 
at CpG sites. Upon DNA replication, the parental strands 
remain methylated, but the newly synthesized strands 
are not. DNA methylases (DNMT) add methyl groups to 
these hemi-methylated CpG sites, thereby maintaining 
the methylation pattern at this location in the next 
generation. (B) In the stochastic model (left), a cell 
containing methylated CpG sites and a silenced 
tumour suppressor gene (TSG) occurs by chance and is 
selected for enhanced growth/survival. Methylation of 
CpG residues is maintained by methylases as described 
in (A). In the instructive model (right), an activated 
oncoprotein (yellow circle) directs DNA methylation of the 
tumour suppressor gene via a classical transcriptional 
pathway involving a sequence-specific DNA binding 
protein (SS-DBP), a co–repressor complex (green circles) 
and DNA methylase. The loss of any component in this 
pathway results in the loss of DNA methylation and the 
increased expression of the tumour suppressor gene. 
The results of Serra et al. support the instructive model: 
these experiments also show that the pathway starts 
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is  inactivated,  non-recruited  DNA  methylases 
(sometimes called maintenance DNA methylases) 
are not sufficient to propagate methylated tumour 
suppressor genes.
More  generally,  epigenetic  inheritance  is 
determined primarily by transcriptional circuitry, 
and not by histone modifications or DNA methyla-
tion (Ptashne, 2013). For example, induced pluri-
potent  stem  cells  (Takahashi  and  Yamanaka, 
2006; Young, 2011) and muscle cells (Weintraub, 
1993) can be generated from other cell lineages 
by introducing the critical transcription factors 
that trigger positive feedback loops involving the 
endogenous factors that define the relevant cell 
type. In fact, the reproductive states of bacterio-
phage λ, a virus that infects E. coli, are epigeneti-
cally  maintained  in  the  absence  of  chromatin 
(Ptashne, 2013).
The  strong  preference  of  DNA  methylases   
for  hemi-methylated  substrates  undoubtedly 
contributes to the stable maintenance of hyper-
methylated tumour suppressor genes (such as 
INK4-ARF). By analogy, other chromatin-modifying 
repressors  both  introduce  repressive  histone 
modifications and preferentially recognise chro-
matin harbouring the modifications they intro-
duced. These include the yeast Sir proteins, which 
remove acetyl groups from histones; HP1, which 
methylates the H3-K9 site; and the polycomb 
complexes,  which  methylate  the  H3-K27  site. 
Thus, both DNA methylation and histone modifi-
cations  are  generated  by  targeted  recruitment   
of enzymatic activities, and these modifications 
serve a reinforcing, but not instructive, role in 
maintaining  epigenetic  states.  While  they  are 
clearly not sufficient, non-recruited DNA methyl-
ases could also contribute to maintaining the 
hypermethylated repressed state by providing 
an  independent  methylation  mechanism  that 
depends on the previous methylation status.
Serra  et  al.  and  the  previous  studies  have   
elucidated the first molecular mechanism for the 
methylation of tumour suppressor genes, namely 
maintenance  by  an  instructive  transcriptional 
mechanism that represses multiple genes. The 
inability  of  non-recruited  DNA  methylases  to 
maintain DNA methylation in cancer cells when 
this transcriptional mechanism has been inacti-
vated casts doubt on the stochastic model and on 
DNA methylation being epigenetically inherited. 
Although  these  are  only  initial  examples,  the 
general  finding  that  DNA  methylation  occurs   
at multiple sites over a localised region strongly 
argues that this instructive model of DNA methyl-
ation is a widespread, and perhaps universal, 
principle in cancer biology.
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with an activated KRAS enzyme (shown here as a yellow 
circle) stimulating the expression of a kinase called 
PRKD1 and its substrate USP28 deubiquitinase (not 
shown). Phosphorylated USP28 removes a ubiquitin 
group from a transcription factor called ZNF304, thus 
increasing its concentration in the nucleus. This 
transcription factor (shown here as SS-DBP) binds to a 
specific region of DNA and recruits a scaffold protein 
called KAP1, an enzyme called SETDB1 that methylates 
histones, and a DNA methylase called DNMT1.
Figure 1. Continued